| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/24/2004 | CA2313122C Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 08/19/2004 | WO2004069831A1 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation |
| 08/19/2004 | WO2004069830A1 Triazole compounds and the therapeutic use thereof |
| 08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
| 08/19/2004 | WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors |
| 08/19/2004 | WO2004069814A1 Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | WO2004069788A1 Carboxylic acid compounds |
| 08/19/2004 | WO2004069139A2 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 08/19/2004 | WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| 08/19/2004 | WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| 08/19/2004 | WO2004058717A8 Isoquinolinone derivatives and their use as therapeutic agents |
| 08/19/2004 | WO2004058705A3 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 08/19/2004 | WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 08/19/2004 | WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/19/2004 | WO2004037807A9 Medicinal arylethanolamine compounds |
| 08/19/2004 | WO2004037784A3 Pyrrolidones with anti-hiv activity |
| 08/19/2004 | WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003032912A8 Treatment of cns disorders using cns target modulators |
| 08/19/2004 | US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 08/19/2004 | US20040162325 phenyloxazole- or thiazole-alkyl-1,3-dioxane or 1,3-dithiane derivatives; therapeutic drugs for lowering blood triglyceride, low-density lipoprotein cholesterol; arteriosclerosis, diabetes mellitus, hypertension, obesity |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/19/2004 | US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 08/19/2004 | US20040162318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162303 4-aminopyrimidine-5-one derivatives |
| 08/19/2004 | US20040162299 Substituted quinazolines and analogs and the use thereof |
| 08/19/2004 | US20040162296 Nitrogen compounds such as 4-(4-(N-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)guanidino)butyl)-N-(2 -aminoethyl)benzamide hydrochloride, administered for prophylaxis of respiratory system disorders; pharmocokinetics |
| 08/19/2004 | US20040162282 Substituted piperazines |
| 08/19/2004 | US20040162278 Triazole compounds useful in therapy |
| 08/19/2004 | US20040162271 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 08/19/2004 | US20040161685 For use in electrophotographic imaging apparatus |
| 08/19/2004 | DE10305739A1 New indolyl-substituted benzofuran derivatives, are 5-HT(1A) agonists and 5-HT reuptake inhibitors useful e.g. as anxiolytic, antidepressant, neuroleptic and/or antihypertensive agents |
| 08/19/2004 | DE10305098A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis |
| 08/19/2004 | DE10304870A1 Triazolverbindungen und ihre therapeutische Verwendung Triazole compounds and their therapeutic use |
| 08/19/2004 | CA2515516A1 Carboxylic acid compounds |
| 08/19/2004 | CA2515116A1 Amino-1,3,5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
| 08/19/2004 | CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | CA2512915A1 4-aminopyrimidine-5-one |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1268436B1 Novel diaminopyrazole derivatives and dyes containing said compounds |
| 08/18/2004 | EP1194426B1 Benzofurane derivatives |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777560 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/17/2004 | US6777559 Process for preparing heterocyclic indene analogs |
| 08/17/2004 | US6777554 Preparation of N-methylparoxetine and related intermediate compounds |
| 08/17/2004 | US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/17/2004 | US6777428 Inhibit peptide extravasation due to stimulation of the trigeminal ganglia, and are therefore useful for the treatment of migraine and associated disorders |
| 08/17/2004 | US6777422 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 08/17/2004 | US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 08/17/2004 | US6777412 Fungicides |
| 08/12/2004 | WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors |
| 08/12/2004 | WO2004067524A1 Ep4 receptor antagonists |
| 08/12/2004 | WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/12/2004 | WO2004067510A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 08/12/2004 | WO2004067489A2 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 08/12/2004 | WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2004 | WO2004052858A3 Inhibitors of monoamine uptake |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 08/12/2004 | WO2004046162A3 Non-steroidal fxr agonists |
| 08/12/2004 | WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/12/2004 | WO2004043392A3 Mucin synthesis inhibitors |
| 08/12/2004 | WO2004032908A3 Method of inhibiting angiogenesis |
| 08/12/2004 | WO2004032871A3 Piperazine and piperazinone inhibitors of factor xa |
| 08/12/2004 | WO2004030635A3 Vasculostatic agents and methods of use thereof |
| 08/12/2004 | WO2004024707A3 Process for preparing amine type substituted benzofurans |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | WO2003092374A3 Pesticidal heterocycles |
| 08/12/2004 | US20040158067 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 08/12/2004 | US20040158064 Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 08/12/2004 | US20040157966 Heat and oxidation resistance; photostability for polymers |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157896 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 08/12/2004 | US20040157894 Thiol compounds, their production and use |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents |
| 08/12/2004 | US20040157885 PPAR activators |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |